scholarly journals Fetal Myelomeningocele Closure: Technical Considerations

2014 ◽  
Vol 37 (3) ◽  
pp. 166-171 ◽  
Author(s):  
Gregory G. Heuer ◽  
N. Scott Adzick ◽  
Leslie N. Sutton

Myelomeningocele (MMC) is one of the most common serious congenital malformations. Typically this condition has been treated with closure of the MMC defect shortly after birth. In general, surgery for MMC aims to provide a multilayered closure to provide protection to the neural elements, prevent leakage of spinal fluid and reduce infection risks. A randomized controlled trial, the Management of Myelomeningocele Study (MOMS), has shown that closure during the fetal period can be performed relatively safely and can result in significant benefit to the child. Whereas the surgical technique of prenatal closure of an MMC defect is similar to a postnatal closure, there are some important technical differences. The goal of this paper is to describe the technique of fetal closure of MMC defects, highlight the unique steps that are needed for this surgery and delineate some potential pitfalls.

2019 ◽  
Vol 76 (1) ◽  
pp. 36-42 ◽  
Author(s):  
Heather E. Hoops ◽  
Karen J. Brasel ◽  
Caroline Q. Stephens ◽  
Erin M. Anderson ◽  
Liane LeBlanc ◽  
...  

2017 ◽  
Vol 225 (4) ◽  
pp. e151-e152
Author(s):  
Heather E. Hoops ◽  
Karen J. Brasel ◽  
Caroline Q. Stephens ◽  
Erin M. Anderson ◽  
Liane LeBlanc ◽  
...  

2018 ◽  
Vol 19 (3) ◽  
pp. 303-312 ◽  
Author(s):  
Stephanie N. Pilieci ◽  
Saad Y. Salim ◽  
Daithi S. Heffernan ◽  
Kamal M.F. Itani ◽  
Rachel G. Khadaroo

2004 ◽  
Vol 16 (2) ◽  
pp. 1-4 ◽  
Author(s):  
Noel Tulipan

Preliminary evidence suggests that intrauterine myelomeningocele repair may benefit patients by reducing the both incidence of hydrocephalus and the severity of the Chiari malformation; however, this benefit remains unproved. Furthermore, the procedure entails substantial risks not associated with conventional therapy. A randomized controlled trial of intrauterine and conventional therapies is underway. This study should definitively establish the procedure-related risks and benefits. Regardless of the outcome, it is clear that the risks of intrauterine intervention need to be reduced before myelomeningocele, or other congenital malformations, can be effectively treated prior to birth. To that end, studies are being conducted to assess the potential advantages of applying state-of-the-art endoscopic techniques to intrauterine therapy. If benefit can be proven and risks reduced, intrauterine myelomeningocele repair has the potential to become the preferred therapy for patients suffering from this debilitating disease.


Sign in / Sign up

Export Citation Format

Share Document